Azienda Ospedaliera Universitaria Senese-L'ospedale Santa Maria alle Scotte

Siena 53100

1 studies enrolling now · 4 studies all time

What they study most

Adjuvant, Castration-resistant Prostate Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma, EGFR, Early Stage Lung Cancer, Exon 20, HNSCC, HRAS Gene Mutation, Hepatocellular Carcinoma, Lung Cancer, NSCLC, Stage IB-IIIA

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors — Stopped early
• Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy — Completed